Which peptides are studied for infections?
Short answer
6 profiles here are grouped under “Infections”: 3 FDA-approved, 1 in clinical trials and 2 not FDA-approved.
Each entry below quotes its profile and links to the full answer there.
FDA-approved 3
In clinical trials 1
Not FDA-approved 2
Not FDA-approved; FDA advised against adding it to the compounding list7,10,11
Not FDA-approved. FDA’s 2024 evaluation states that it is not a component of an FDA-approved drug, and FDA lists it among compounding substances that may present significant safety risks.7,10
Is thymosin alpha-1 FDA-approved? · Thymosin alpha-1 vs Thymosin beta-4
PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.
Citations
Sources
Numbered markers in the text point here. Each link opens the original public record.
- 1Drugs@FDA: DALVANCE (dalbavancin hydrochloride), NDA 021883 · original approval May 23, 2014 ↗
U.S. Food and Drug Administration · Official source · Source checked November 16, 2026
- 2DALVANCE (dalbavancin) for injection · SPL version 29 · published 2025-11-17 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 16, 2026
- 3CUBICIN RF (daptomycin) injection, powder, lyophilized, for solution · SPL version 22 · published 2025-06-20 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 4Drugs@FDA: CUBICIN and CUBICIN RF (daptomycin), NDA 021572 · original approval September 12, 2003 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 5Drugs@FDA: FUZEON (enfuvirtide), NDA 021481 · original approval March 13, 2003 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 6Aviptadil substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 15, 2026
- 7Certain bulk drug substances for use in compounding that may present significant safety risks ↗
U.S. Food and Drug Administration · Official source · Source checked November 14, 2026
- 8Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial (2023) · PMID 37348524 ↗
The Lancet Respiratory Medicine · Official source · Source checked November 15, 2026
- 9Thymopentin substance identity record ↗
FDA Global Substance Registration System · Official source · Source checked November 16, 2026
- 10FDA evaluation of thymosin alpha-1-related bulk drug substances, November 15, 2024 (briefing document for the December 4, 2024 Pharmacy Compounding Advisory Committee) ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 11December 4, 2024 Meeting of the Pharmacy Compounding Advisory Committee · minutes ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026